• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型糖原贮积病患者乙醇快速清除是反复低血糖引起的一种适应性变化。

Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.

作者信息

Greene H L, Parker P H, Hoyumpa A M, Hall S D

出版信息

J Lab Clin Med. 1986 Feb;107(2):118-22.

PMID:3456005
Abstract

Patients with deficient activity of hepatic glucose-6-phosphatase (glycogen storage disease type I [GSD-I]) have fasting-induced hypoglycemia, lactic acidemia, hyperuricemia, hyperlipidemia, and a markedly increased capacity for ethanol elimination. The mechanism(s) responsible for the rapid ethanol elimination is not known but has been thought to be directly related to the enzyme defect. We postulated however, that the increased elimination of ethanol was an adaptive phenomenon that would revert toward normal with correction of other blood abnormalities by long-term maintenance of normal blood glucose concentration. Six patients were observed before treatment (group A), and four of the six were observed again 3 to 6 months after dietary treatment had normalized all blood abnormalities (group B). Patients received 16 ml/m2 absolute ethanol as a 5% solution in 0.9% sodium chloride over a 20-minute period. The rate of ethanol elimination was significantly greater (P less than 0.03) in group A than in group B (55.1 +/- 11.1 vs. 37.5 +/- 8.6 mg/dl/hr). Changes in lactate level after ethanol were also significant between the two groups (P less than 0.005). Group A showed a decrease from 9.4 +/- 0.5 to 6.4 +/- 0.4 mEq/L, whereas group B showed an increase in lactate level from 2.7 +/- 0.2 to 4.4 +/- 0.64 mEq/L. Ethanol induced no significant change in blood glucose concentration in group A, whereas there was a significant increase (P less than 0.03) in group B from 93 +/- 6 to 123 +/- 9 mg/dl.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

肝葡萄糖-6-磷酸酶活性缺乏的患者(I型糖原贮积病[GSD-I])会出现空腹诱导的低血糖、乳酸性血症、高尿酸血症、高脂血症,以及乙醇清除能力显著增强。导致乙醇快速清除的机制尚不清楚,但一直被认为与酶缺陷直接相关。然而,我们推测,乙醇清除增加是一种适应性现象,通过长期维持正常血糖浓度纠正其他血液异常后,这种现象会恢复正常。观察了6例治疗前的患者(A组),其中4例在饮食治疗使所有血液异常恢复正常3至6个月后再次接受观察(B组)。患者在20分钟内接受16 ml/m2的无水乙醇,以5%的溶液溶于0.9%的氯化钠中。A组的乙醇清除率显著高于B组(P<0.03)(55.1±11.1对37.5±8.6 mg/dl/小时)。两组之间乙醇摄入后乳酸水平的变化也有显著差异(P<0.005)。A组乳酸水平从9.4±0.

相似文献

1
Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.I型糖原贮积病患者乙醇快速清除是反复低血糖引起的一种适应性变化。
J Lab Clin Med. 1986 Feb;107(2):118-22.
2
ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.ATP耗竭,在I型糖原贮积病高尿酸血症发病机制中的可能作用。
J Clin Invest. 1978 Aug;62(2):321-8. doi: 10.1172/JCI109132.
3
Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study.1型糖原贮积病青年成人肝脏和脑代谢特征:一项磁共振波谱研究
Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1378-84. doi: 10.1152/ajpendo.00658.2006. Epub 2007 Sep 4.
4
NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.美国国家毒理学计划关于邻苯二甲酸二丁酯(化学物质登记号84 - 74 - 2)经饲料给予F344/N大鼠和B6C3F1小鼠的毒性研究技术报告。
Toxic Rep Ser. 1995 Apr;30:1-G5.
5
Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).冯·吉尔克病(I型糖原贮积病)中的继发性代谢变化。
Ann Clin Lab Sci. 1982 Sep-Oct;12(5):424-30.
6
Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.持续夜间胃内喂养用于1型糖原贮积病的治疗
N Engl J Med. 1976 Feb 19;294(8):423-5. doi: 10.1056/NEJM197602192940805.
7
NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.国家毒理学计划关于给F344/N大鼠和B6C3F1小鼠饮用含氨基甲酸乙酯的水以及饮用含5%乙醇的氨基甲酸乙酯的毒性研究技术报告。
Toxic Rep Ser. 1996 Mar(52):1-91, A1-9, B1-9 passim.
8
The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.I型糖原贮积病患儿采用缓释碳水化合物的饮食治疗
Pediatr Res. 1984 Sep;18(9):879-81. doi: 10.1203/00006450-198409000-00015.
9
Long-term results of living donor liver transplantation for glycogen storage disorders in children.儿童糖原贮积病活体肝移植的长期结果
Liver Transpl. 2007 Jun;13(6):848-52. doi: 10.1002/lt.21151.
10
The pathogenesis of hyperuricemia in glycogen storage disease, type I.I型糖原贮积病中高尿酸血症的发病机制。
Pediatr Res. 1977 May;11(5):664-9. doi: 10.1203/00006450-197705000-00008.